Explore evidence

13.5 %Only 13.5% of the participants expressed the correct perceptions of the complementary relationship between HIV and TB.

Nigeriatuberculose · VIH/sidapublished 2024BMC public healthPubMeddocument of 4 observations

47.6 %Almost half (47.6%) of the facilities experienced a stock out of TB drugs in the 3 months preceding the study.

Nigeriatuberculoseobserved 3 months preceding the studypublished 2020BMC health services researchPubMeddocument of 14 observations

33 monthsThe non-parametric median survival time of TB patients co-infected with HIV was 33 months.

Nigeriatuberculose · VIH/sidapublished 2020PloS onePubMeddocument of 4 observations

3.1 %Two (3.1%) of the 65 patients with MTB detection had rifampicin resistance.

Nigeriatuberculosepublished 2025West African journal of medicinePubMeddocument of 7 observations

51 monthsThe non-parametric median survival time of TB patients was 51 months.

Nigeriatuberculosepublished 2020PloS onePubMeddocument of 4 observations

10 %Of the 24,802 presumptive tuberculosis cases, 10% were diagnosed with tuberculosis, representing 0.23% of all individuals screened.

Nigeriatuberculosepublished 2024Global health, science and practicePubMeddocument of 15 observations

16.7 %At 9 months, 16.7% of TB patients had positive IgG levels.

Nigeriatuberculosepublished 2022Frontiers in cellular and infection microbiologyPubMeddocument of 15 observations

7.4 %Among 404 patients with tuberculosis in Oyo State, South-west Nigeria, 30 (7.4%) had impaired fasting glucose.

Nigeriaimpaired fasting glucose · tuberculosepublished 2022BMJ openPubMeddocument of 7 observations

102 casesThe highest number of tuberculosis cases under treatment was 102 (24.0%) in 2013.

Nigeriatuberculoseobserved 2013published 2022African health sciencesPubMeddocument of 17 observations

11 daysSD Bioline MPT64 achieved a shorter median time to identification of MTBC at 11 days compared to 26 days by the conventional method.

Nigeriatuberculosepublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 6 observations

0.164 p-valueThe McNemar test showed no significant difference between stool and sputum GeneXpert results (p = 0.164).

Nigeriatuberculosepublished 2026BMC infectious diseasesPubMeddocument of 10 observations

83.3 %One hundred eighty-four (83.3%) of the 221 presumptive tuberculosis cases were sent for Xpert MTB/Rif assay.

Nigeriadiabète (non précisé) · tuberculosepublished 2020Advances in respiratory medicinePubMeddocument of 7 observations

0.36 correlation_coefficientOn bivariate analysis, higher case mortality rate (CMR) correlated positively with TB prevalence (r=0.36).

Nigeriatuberculosepublished 2020The Pan African medical journalPubMeddocument of 6 observations

13.9 %Out of 1,146,560 patients screened, there were 3,384 (13.9%) confirmed TB cases.

Nigeriatuberculosepublished 2020PloS onePubMeddocument of 10 observations

34 yearsThe mean age of the drug-susceptible tuberculosis (DS-TB) group was 34 years.

Nigeriatuberculosepublished 2024Journal of global antimicrobial resistancePubMeddocument of 8 observations

70 %70% of the drug-resistant tuberculosis (DR-TB) group reported drinking unpasteurised milk.

Nigeriatuberculosepublished 2024Journal of global antimicrobial resistancePubMeddocument of 8 observations

13.3 aORInmates with pretreatment weight of 55 kg or more had an adjusted odds ratio of 13.3 for successful TB treatment compared to those with weight below 55 kg.

Nigeriatuberculoseobserved 2014–2018published 2022PloS onePubMeddocument of 11 observations

200 copies/mLA high viral load (>200 copies/mL) at baseline was associated with increased risk of tuberculosis in the SECOND-LINE trial.

Nigeriatuberculosepublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

17.04 pointsThe overall mean HRQoL score obtained at enrolment was 43.18 and 60.22 at end of 2 months; mean change = 17.04 (p<0.001).

Nigeriatuberculosepublished 2018Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 6 observations

Tuberculosis is the world's deadliest infectious disease and a leading cause of death in Nigeria.

Nigeriatuberculosepublished 2020BMC health services researchPubMeddocument of 14 observations

63.9 %Pulmonary tuberculosis was diagnosed in 23 (63.9%) of the 36 children.

Nigeriatuberculosepublished 2026Annals of African medicinePubMeddocument of 11 observations

100 %The combined stool and sputum GeneXpert testing achieved 100% negative predictive value (NPV).

Nigeriatuberculosepublished 2026BMC infectious diseasesPubMeddocument of 10 observations

12.5 %The tuberculosis loss to follow-up rate was 12.5% among 241 TB patients in a semi-urban tuberculosis center in Southeast Nigeria between September 2014 and August 2017.

Nigeriatuberculoseobserved September 2014 and August 2017published 2021West African journal of medicinePubMeddocument of 10 observations

45.27 scoreHRQOL scores in the 'environment' domain increased from 45.27 ± 14.59 to 61.28 ± 15.86 over the treatment period.

Nigeriatuberculosepublished 2024Quality of life research : an international journal of quality of life aspects of treatmenPubMeddocument of 5 observations

27.8 %The proportion of tuberculosis patients who completed treatment was 27.8%.

Nigeriatuberculoseobserved 2012-2016published 2022African health sciencesPubMeddocument of 17 observations